pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

Reported via Drug Recalls & Safety Alerts (Recalls-rappels Canada).

ScopeUp summarizes Ontario practice updates and links every item to its official source. Verify details against the source document before changing workflows.